Thrombosis Drugs Market Expected to Reach Nearly USD 52.3 Billion by 2033, Driven by Rising Thromboembolic Disorders and Growing Adoption of Safer Anticoagulants The global thrombosis drugs market — valued at approximately USD 26.11 billion in 2024 — is projected to grow to about USD 52.30 billion by 2033, powered by increasing prevalence of thrombotic conditions...